Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients

INTRODUCTION: Advancements in chemotherapy treatment have improved the clinical management of metastatic colon cancer (mCC) patients. An increasing number of elderly mCC patients receive various combinations of regimens in second-line chemotherapy/biologics treatment (Tx2) after first-line treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhiyuan, Onukwugha, Eberechukwu, Hanna, Nader, Bikov, Kaloyan, Seal, Brian, Mullins, C. Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115177/
https://www.ncbi.nlm.nih.gov/pubmed/25022528
http://dx.doi.org/10.1007/s12325-014-0134-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4115177/
https://www.ncbi.nlm.nih.gov/pubmed/25022528
http://dx.doi.org/10.1007/s12325-014-0134-8

Ejemplares similares